Correction to: Sutimlimab improves quality of life in patients with cold agglutinin disease: results of patientreported outcomes from the CARDINAL study.

This document is a correction notice for an article titled "Sutimlimab improves quality of life in patients with cold agglutinin disease: results of patient-reported outcomes from the CARDINAL study" published in the Annals of Hematology. The correction addresses an error in the description of the possible score range of the SF-12 Mental Component Summary (MCS) and Physical Component Summary (PCS). The correct information is that the scores for MCS and PCS are on a T-metric, with a mean of 50 and a standard deviation of 10, referenced to the US general population. The original article has been corrected. [Extracted from the article]